Family · Pharmaceutical analytical standards
Lesinurad
An inhibitor of the renal transporter URAT1 that increases the excretion of uric acid in urine, approved in the United States in 2015 for gout in combination with a xanthine oxidase inhibitor. This family brings together the active ingredient, metabolites and other impurities.
Did you know?It was born by chance from an HIV programme: the drop in uric acid seen with an antiviral candidate was traced to one of its metabolites, from which researchers developed lesinurad.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
